← Open Payments lookup

MICHELLE THARP: Open Payments

NPI 1720528011 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$21,864 in 55 payments from 10 companies in 2025. Trend: 2023 $51 · 2024 $5,364 · 2025 $21,864

Speaker / faculty: $11,715Travel & lodging: $5,359Consulting: $3,458Food & beverage: $1,182Honoraria: $150
CompanyPaymentsAmount
BioMarin Pharmaceutical Inc.33$18,894
PTC Therapeutics, Inc.5$1,441
Chiesi USA, Inc.3$1,035
GENZYME CORPORATION5$213
Takeda Pharmaceuticals U.S.A., Inc.3$89
Ultragenyx Pharmaceutical Inc.2$53
Orchard Therapeutics North America1$44
Zevra Therapeutics Inc1$43
Cycle Pharmaceuticals Inc1$37
IntraBio Inc1$15

Products named: Palynziq, SEPHIENCE, ELFABRIO, LAMZEDE, FABRAZYME, Kuvan, Dojolvi, ELAPRASE.

Industry payments across MS — which companies pay providers there.